Clinical Trials Directory

Trials / Conditions / Stage IV Renal Pelvis Cancer AJCC v8

Stage IV Renal Pelvis Cancer AJCC v8

8 registered clinical trials studyying Stage IV Renal Pelvis Cancer AJCC v8.

StatusTrialSponsorPhase
Active Not RecruitingTesting Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemo
NCT04963153
National Cancer Institute (NCI)Phase 1
Active Not RecruitingTesting the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in
NCT05092958
National Cancer Institute (NCI)Phase 3
Active Not RecruitingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or
NCT04940299
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingARID1A and/or KDM6A Mutation and CXCL13 Expression
NCT04953104
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingImmune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma
NCT04848519
Emory UniversityPhase 2
TerminatedGemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary
NCT04398368
Mayo ClinicPhase 2
CompletedAtezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial C
NCT03513952
National Cancer Institute (NCI)Phase 2
Active Not RecruitingAtezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metasta
NCT03237780
National Cancer Institute (NCI)Phase 2